Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1130047.RAFOIdrO-Ef_6rpJ6WqLMtxJ3fr7DZ2wPOlKRA_BnmkkY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1130047.RAFOIdrO-Ef_6rpJ6WqLMtxJ3fr7DZ2wPOlKRA_BnmkkY130_assertion type Assertion NP1130047.RAFOIdrO-Ef_6rpJ6WqLMtxJ3fr7DZ2wPOlKRA_BnmkkY130_head.
- NP1130047.RAFOIdrO-Ef_6rpJ6WqLMtxJ3fr7DZ2wPOlKRA_BnmkkY130_assertion description "[Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130047.RAFOIdrO-Ef_6rpJ6WqLMtxJ3fr7DZ2wPOlKRA_BnmkkY130_provenance.
- NP1130047.RAFOIdrO-Ef_6rpJ6WqLMtxJ3fr7DZ2wPOlKRA_BnmkkY130_assertion evidence source_evidence_literature NP1130047.RAFOIdrO-Ef_6rpJ6WqLMtxJ3fr7DZ2wPOlKRA_BnmkkY130_provenance.
- NP1130047.RAFOIdrO-Ef_6rpJ6WqLMtxJ3fr7DZ2wPOlKRA_BnmkkY130_assertion SIO_000772 24259277 NP1130047.RAFOIdrO-Ef_6rpJ6WqLMtxJ3fr7DZ2wPOlKRA_BnmkkY130_provenance.
- NP1130047.RAFOIdrO-Ef_6rpJ6WqLMtxJ3fr7DZ2wPOlKRA_BnmkkY130_assertion wasDerivedFrom befree-2016 NP1130047.RAFOIdrO-Ef_6rpJ6WqLMtxJ3fr7DZ2wPOlKRA_BnmkkY130_provenance.
- NP1130047.RAFOIdrO-Ef_6rpJ6WqLMtxJ3fr7DZ2wPOlKRA_BnmkkY130_assertion wasGeneratedBy ECO_0000203 NP1130047.RAFOIdrO-Ef_6rpJ6WqLMtxJ3fr7DZ2wPOlKRA_BnmkkY130_provenance.